Published in J Am Coll Cardiol on March 29, 2016
Drug-Eluting Stents: Capable of Saving Lives in Dialysis Patients? J Am Coll Cardiol (2016) 0.76
Comparison of Drug-Eluting and Bare Metal Stents in Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis. J Am Heart Assoc (2016) 0.75
Coronary Revascularization in Patients with CKD Stage 5D: Pragmatic Considerations. J Am Soc Nephrol (2016) 0.75
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med (2009) 8.25
K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis (2005) 6.31
Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol (2006) 6.07
Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med (2007) 5.77
Estimating causal effects from epidemiological data. J Epidemiol Community Health (2006) 5.61
Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med (2007) 4.95
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use. Stat Med (2006) 3.87
Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation (2012) 3.14
Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation (2013) 2.47
Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int (2000) 2.19
Platelet dysfunction and end-stage renal disease. Semin Dial (2006) 2.09
Unanswered questions--drug-eluting stents and the risk of late thrombosis. N Engl J Med (2007) 1.70
Cardiac survival after pre-emptive coronary angiography in transplant patients and those awaiting transplantation. Clin J Am Soc Nephrol (2011) 1.70
Blood pressure and mortality risk on peritoneal dialysis. Am J Kidney Dis (2008) 1.68
Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database. J Am Coll Cardiol (2011) 1.68
Propensity score methods for confounding control in nonexperimental research. Circ Cardiovasc Qual Outcomes (2013) 1.62
Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization. J Invasive Cardiol (2006) 1.61
Stent thrombosis redux--the FDA perspective. N Engl J Med (2007) 1.60
Survival benefit with drug-eluting stents in observational studies: fact or artifact? Circ Cardiovasc Qual Outcomes (2011) 1.59
Major bleeding in hemodialysis patients. Clin J Am Soc Nephrol (2007) 1.51
Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD. J Am Soc Nephrol (2012) 1.42
Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates. Pharmacoepidemiol Drug Saf (2013) 1.15
Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients. Am J Kidney Dis (2007) 1.14
Acceptance, panic, and partial recovery the pattern of usage of drug-eluting stents after introduction in the U.S. (a report from the American College of Cardiology/National Cardiovascular Data Registry). JACC Cardiovasc Interv (2010) 1.09
Angiographical severity of coronary atherosclerosis predicts death in the first year of hemodialysis. Int Urol Nephrol (2003) 1.04
Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J (2008) 1.04
Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J (2007) 1.01
Drug-eluting coronary stents--promise and uncertainty. N Engl J Med (2007) 0.99
Biphasic effects of hemodialysis on platelet reactivity in patients with end-stage renal disease: a potential contributor to cardiovascular risk. Am J Kidney Dis (2002) 0.96
One-year clinical outcomes of dialysis patients after implantation with sirolimus-eluting coronary stents. Circ J (2008) 0.89
Long-term clinical outcomes after sirolimus-eluting stent implantation in dialysis patients. Int Heart J (2010) 0.89
Randomized Comparison of Xience V and Multi-Link Vision Coronary Stents in the Same Multivessel Patient With Chronic Kidney Disease (RENAL-DES) Study. Circulation (2013) 0.86
Medicare from A to D: what every nephrologist needs to know. Clin J Am Soc Nephrol (2008) 0.84
Impact of moderate renal insufficiency on restenosis and adverse clinical events after sirolimus-eluting and bare metal stent implantation (from the SIRIUS trials). Am J Cardiol (2010) 0.83
Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. Circulation (2011) 0.83
Thienopyridine use after coronary stenting in low income patients enrolled in medicare part D receiving maintenance dialysis. J Am Heart Assoc (2014) 0.82
Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean multicenter angioplasty team (KOMATE) Registry. J Interv Cardiol (2009) 0.82
Percutaneous coronary intervention with bare metal stent vs. drug-eluting stent in hemodialysis patients. Circ J (2012) 0.81
Instrumental variable analysis to compare effectiveness of stents in the extremely elderly. Circ Cardiovasc Qual Outcomes (2013) 0.81